On-Demand Webinars
-
Deciphering The Complexity Of Therapeutic Biologics
3/26/2026
This session breaks down essential analytical approaches that strengthen biologics development, from defining critical quality attributes to supporting comparability and regulatory readiness.
-
Unlock The Potential Of GPEx Lightning Accelerate Your HEK Cell Line Development
3/25/2026
Discover how an advanced cell line development platform now supports HEK cells alongside CHO, enabling rapid, scalable production of complex biologics while saving up to 12 weeks on development timelines.
-
Flexible Therapeutic Development: Balancing Speed, Cost, and Process
3/24/2026
Microbial development for first‑in‑human studies requires coordinated cell line, fermentation, and purification strategies to accelerate timelines while controlling cost and process robustness.
-
Overcoming Hurdles In Protein Therapy Manufacturing
3/24/2026
Learn how biopharmaceutical leaders address scalability, quality control, and regulatory challenges when manufacturing protein-based therapies at commercial scale.
-
Achieving Rapid, High-Titer Expression For Next-Generation Biologics
3/24/2026
Uncover how tunable expression technology achieves optimal chain pairing and high titers for complex biologics, from four-chain bispecifics to difficult-to-express proteins, using platform processes.
-
Accelerating Vector Construction-To-IND: Achieving A 9-Month Timeline Through Integrated Cell Line Development
3/19/2026
Uncover how tighter alignment between vector construction and cell banking improved development efficiency, strengthened risk management, and enhanced early-stage program outcomes.
-
How AI-Enabled Validation Technologies Enable The Predictive Plant
3/18/2026
Discover how AI-enabled digital validation shifts manufacturers from reactive compliance to predictive intelligence, connecting validation, asset, and quality data to accelerate digital maturity.
-
Enhanced Biotherapeutic Protein Expression Using Advanced Vector Systems
3/18/2026
Learn how optimized expression vector design and data-driven strategies can significantly enhance product titre, quality, and long-term gene expression stability in GS-CHO cell-based manufacturing.
-
Eliminating Barriers To In Vivo And Ex Vivo CAR-T Delivery
3/17/2026
Learn how lentiviral vector processes evolve for in vivo and ex vivo CAR‑T—covering yield, purity, scalability, and shifting regulatory demands for safe, consistent systemic delivery.
-
What Matters More In DNA-Encoded Libraries?
3/16/2026
DELs can screen billions of compounds, but library quality determines meaningful results. See how thoughtful design shapes early decisions that influence which drug candidates move forward.